Profile

Donna Kersey
	Lab Manager, Perlman Laboratory dkersey@childrensmemorial.org Children's Memorial Research Center 2430 N. Halsted St Room C303A Chicago, IL 60614 Phone: (773) 755-6544

Education
	Year	DegreeB.S.	InstitutionUniversity of Kentucky

Work Experience
	Period	Description	Organization
	July 2002 - Present	lab manager	Children's Memorial Hospital, Department of Pathology, Chicago, IL
	December 1990 - May 2002	lab manager	Chicago Institute for Neurosurgery and Neuroresearch, Chicago, IL and Evanston, IL
	May 1990 - December 1990	research technologist II	Northwestern University, Department of Pharmacology and The Cancer Center, Chicago, IL
	March 1989 - May 1990	research assistant	Synergen, Department of Pharmaceutics, Boulder, CO
	September 1988 - March 1989	senior research analyst	University of Kentucky, Department of Pathology and The Cancer Center, Lexington, KY
	October 1986 - September 1988	senior research analyst	University of Kentucky, Department of Microbiology and Immunology and The Cancer Center, Lexington, KY
	November 1981 - December 1984	lecturer and translator	Technical University of Wroclaw, Department of Foreign Language, Wroclaw, Poland
	1980 - 1981	research analyst	University of Kentucky, Department of Biochemistry and The Sanders-Brown Center on Aging, Lexington, KY
	1977 - 1980	principal laboratory technician	University of Kentucky, Department of Chemistry, Lexington, KY

Lab Affiliations
	Perlman Lab

Recent Publications

C. Cutcliffe, D. Kersey, C-C Huang, Y. Zeng, D. Walterhouse, E.J. Perlman for the Renal Tumor Committee of the Children's Oncology Group (2005). Clear cell sarcoma of the kidney: Up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clinical Cancer Research: Nov 15; 11(22):7986 - 7994.
( Download Adobe Acrobat PDF )

Q. Yang, S. Liu, Y. Tian, C. Hasan, D. Kersey, H. Salwen, A. Chlenski, E. Perlman and S. Cohn (2004). Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma. Cancer Research : July 1;64:4531-4538.

R.A. Kroes, A. Jastrow, M.G. McLone, H. Yamamoto, P. Colley, D.S. Kersey, V.W. Yong, E. Mkrdichian, L. Cerullo, J. Leestma and J.R. Moskal (2000). The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Letters: Aug11;156 (2):191-198.

A. Rebbaa, H. Yamamoto, T. Saito, E. Meuillet, P. Kim, D.S. Kersey, E.G. Bremer, N. Taniguchi and J. R. Moskal (1997). Gene transfection-mediated overexpression of beta1,4GlcNAc bisecting oligosaccharides in glioma cell line U373 MG inhibits EGF receptor function. Journal of Biological Chemistry : Apr 4; 272 (14):9275-.

H. Yamamoto, T. Saito, Y. Kaneko, D. Kersey, V.W. Yong, E.G. Bremer, E. Mkrdichian, L. Cerullo, J. Leestma and J.R. Moskal (1997). Alpha2,3-sialyltransferase mRNA and alpha2,3-linked glycoprotein sialylation are increased in malignant gliomas . Brain Research : 755:175-179.

Y. Kaneko, H. Yamamoto, D. Kersey, K. Colley, J. Leestma, and J. Moskal (1996). The expression of Galbeta1,4GlcNAc alpha2,6 sialyltransferase and alpha2,6-linked sialoglycoconjugates in human brain tumors. Acta Neuropathologica : 91:284-292.

A. Rebbaa, J. Hurh, H. Yamamoto, D. Kersey and E. Bremer (1996). Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology 6: 399-406.

H. Yamamoto, Y. Kaneko, D. VanderMeulen, D. Kersey, E. Mkrdichian, L. Cerullo, and J. Moskal (1995). The expression of CMP-NeuAc:Galbeta1,4 GlcNAc alpha2,6 sialyltransferase and glycoproteins bearing alpha2,6-linked sialic acids in human brain tumors. Glycoconjugate Journal : 12:848-856.

M. Turker, K. Duffin, A. Smith, G. Martin, A. Martin, D. DiMartino, and D. Kersey (1991). Multidrug resistance phenotype associated with selection of an aminopterin resistant dog kidney cell line. Pharmacogenetics : 1:149-160.

Recent Presentations
	D. Kersey, C. Hasan, P. Grundy, E. J. Perlman (March, 2003). Genetic expression profiling of clear cell sarcoma of the kidney (CCSK). platform presentation, Society for Pediatric Pathology Annual Meeting. Washington, DC.